Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients
Status:
Terminated
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
Chloroquine might very well be able to increase overall survival in small cell lung cancer by
sensitizing cells resistant to chemotherapy and radiotherapy.
Phase:
Phase 1
Details
Lead Sponsor:
Maastricht Radiation Oncology
Collaborators:
Maastricht University Medical Center National Cancer Institute (NCI)